Cancer Genome Sequencing Market Report

Europe Cancer Genome Sequencing Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 11, 2020
  • PAGES：221
  • REPORT CODE：GMM543570
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Cancer Genome Sequencing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Cancer Genome Sequencing Market Segmentations:

    By Player:

    • Myriad Genetics

    • Abbott Laboratories

    • GE Healthcare Life Sciences

    • Pacific Biosciences

    • ZS Genetics

    • Hamilton Thorne Biosciences

    • Agilent Technologies

    • Bayer Corporation

    • Microchip Biotechnologies

    • LI-COR Biosciences

    • Johnson & Johnson

    • Beckman Coulter

    • Commonwealth Biotechnologies

    By Type:

    • Second generation

    • Third generation

    By End-User:

    • Treatment

    • Research

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Genome Sequencing Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Cancer Genome Sequencing Market Size and Growth Rate of Second generation from 2014 to 2026

    • 1.3.2 Europe Cancer Genome Sequencing Market Size and Growth Rate of Third generation from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Cancer Genome Sequencing Market Size and Growth Rate of Treatment from 2014 to 2026

    • 1.4.2 Europe Cancer Genome Sequencing Market Size and Growth Rate of Research from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cancer Genome Sequencing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Genome Sequencing by Major Types

      • 3.4.1 Market Size and Growth Rate of Second generation

      • 3.4.2 Market Size and Growth Rate of Third generation

    4 Segmentation of Cancer Genome Sequencing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Genome Sequencing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Treatment for Construction

      • 4.4.2 Market Size and Growth Rate of Research for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Cancer Genome Sequencing Production Analysis by Top Regions

    • 5.2 Europe Cancer Genome Sequencing Consumption Analysis by Top Regions

    • 5.3 Europe Cancer Genome Sequencing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.3 France Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cancer Genome Sequencing Market among Top Countries

    • 6.1 Top 5 Export Countries in Cancer Genome Sequencing Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cancer Genome Sequencing Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cancer Genome Sequencing Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cancer Genome Sequencing Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Cancer Genome Sequencing Landscape Analysis

    • 7.1 Germany Cancer Genome Sequencing Landscape Analysis by Major Types

    • 7.2 Germany Cancer Genome Sequencing Landscape Analysis by Major End-Users

    8. UK Cancer Genome Sequencing Landscape Analysis

    • 8.1 UK Cancer Genome Sequencing Landscape Analysis by Major Types

    • 8.2 UK Cancer Genome Sequencing Landscape Analysis by Major End-Users

    9. France Cancer Genome Sequencing Landscape Analysis

    • 9.1 France Cancer Genome Sequencing Landscape Analysis by Major Types

    • 9.2 France Cancer Genome Sequencing Landscape Analysis by Major End-Users

    10. Italy Cancer Genome Sequencing Landscape Analysis

    • 10.1 Italy Cancer Genome Sequencing Landscape Analysis by Major Types

    • 10.2 Italy Cancer Genome Sequencing Landscape Analysis by Major End-Users

    11. Spain Cancer Genome Sequencing Landscape Analysis

    • 11.1 Spain Cancer Genome Sequencing Landscape Analysis by Major Types

    • 11.2 Spain Cancer Genome Sequencing Landscape Analysis by Major End-Users

    12. Poland Cancer Genome Sequencing Landscape Analysis

    • 12.1 Poland Cancer Genome Sequencing Landscape Analysis by Major Types

    • 12.2 Poland Cancer Genome Sequencing Landscape Analysis by Major End-Users

    13. Russia Cancer Genome Sequencing Landscape Analysis

    • 13.1 Russia Cancer Genome Sequencing Landscape Analysis by Major Types

    • 13.2 Russia Cancer Genome Sequencing Landscape Analysis by Major End-Users

    14. Switzerland Cancer Genome Sequencing Landscape Analysis

    • 14.1 Switzerland Cancer Genome Sequencing Landscape Analysis by Major Types

    • 14.2 Switzerland Cancer Genome Sequencing Landscape Analysis by Major End-Users

    15. Turkey Cancer Genome Sequencing Landscape Analysis

    • 15.1 Turkey Cancer Genome Sequencing Landscape Analysis by Major Types

    • 15.2 Turkey Cancer Genome Sequencing Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Landscape Analysis by Top Countries

      • 16.3.1 Denmark Cancer Genome Sequencing Market Volume and Growth Rate

      • 16.3.2 Finland Cancer Genome Sequencing Market Volume and Growth Rate

      • 16.3.3 Norway Cancer Genome Sequencing Market Volume and Growth Rate

      • 16.3.4 Sweden Cancer Genome Sequencing Market Volume and Growth Rate

      • 16.3.6 Iceland Cancer Genome Sequencing Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Landscape Analysis by Top Countries

      • 17.3.1 Belgium Cancer Genome Sequencing Market Volume and Growth Rate

      • 17.3.2 Netherlands Cancer Genome Sequencing Market Volume and Growth Rate

      • 17.3.3 Luxembourg Cancer Genome Sequencing Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Landscape Analysis by Top Countries

      • 18.3.1 Estonia Cancer Genome Sequencing Market Volume and Growth Rate

      • 18.3.2 Latvia Cancer Genome Sequencing Market Volume and Growth Rate

      • 18.3.3 Lithuania Cancer Genome Sequencing Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Myriad Genetics

      • 19.1.1 Myriad Genetics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Abbott Laboratories

      • 19.2.1 Abbott Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 GE Healthcare Life Sciences

      • 19.3.1 GE Healthcare Life Sciences Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pacific Biosciences

      • 19.4.1 Pacific Biosciences Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 ZS Genetics

      • 19.5.1 ZS Genetics Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Hamilton Thorne Biosciences

      • 19.6.1 Hamilton Thorne Biosciences Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Agilent Technologies

      • 19.7.1 Agilent Technologies Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Bayer Corporation

      • 19.8.1 Bayer Corporation Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Microchip Biotechnologies

      • 19.9.1 Microchip Biotechnologies Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 LI-COR Biosciences

      • 19.10.1 LI-COR Biosciences Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Johnson & Johnson

      • 19.11.1 Johnson & Johnson Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Beckman Coulter

      • 19.12.1 Beckman Coulter Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Commonwealth Biotechnologies

      • 19.13.1 Commonwealth Biotechnologies Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 107 Figures and 202 Tables)

    • Figure Product Picture

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Second generation Market, 2015 - 2026 (USD Million)

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Third generation Market, 2015 - 2026 (USD Million)

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Treatment from 2014 to 2026

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Research from 2014 to 2026

    • Figure Germany Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure France Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Cancer Genome Sequencing Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cancer Genome Sequencing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cancer Genome Sequencing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Genome Sequencing by Different Types from 2014 to 2026

    • Table Consumption Share of Cancer Genome Sequencing by Different Types from 2014 to 2026

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Second generation Market, 2015 - 2026 (USD Million)

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Third generation Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cancer Genome Sequencing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cancer Genome Sequencing by Different End-Users from 2014 to 2026

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Treatment from 2014 to 2026

    • Figure Cancer Genome Sequencing Market Size and Growth Rate of Research from 2014 to 2026

    • Table Europe Cancer Genome Sequencing Production by Major Regions

    • Table Europe Cancer Genome Sequencing Production Share by Major Regions

    • Figure Europe Cancer Genome Sequencing Production Share by Major Countries and Regions in 2014

    • Table Europe Cancer Genome Sequencing Consumption by Major Regions

    • Table Europe Cancer Genome Sequencing Consumption Share by Major Regions

    • Table Germany Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table UK Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table France Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Italy Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Spain Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Poland Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Russia Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Switzerland Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Turkey Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cancer Genome Sequencing Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Germany Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Germany Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Germany Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table UK Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table UK Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table UK Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table UK Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table France Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table France Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table France Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table France Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Italy Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Italy Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Italy Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Italy Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Spain Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Spain Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Spain Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Spain Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Poland Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Poland Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Poland Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Poland Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Russia Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Russia Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Russia Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Russia Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Switzerland Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Switzerland Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Switzerland Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Turkey Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Turkey Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Turkey Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Genome Sequencing Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Genome Sequencing Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Genome Sequencing Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Cancer Genome Sequencing Market Volume and Growth Rate from 2014 to 2026

    • Table Myriad Genetics Profiles

    • Table Myriad Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table Myriad Genetics Product benchmarking

    • Table Myriad Genetics Strategic initiatives

    • Table Myriad Genetics SWOT analysis

    • Table Abbott Laboratories Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Abbott Laboratories Product benchmarking

    • Table Abbott Laboratories Strategic initiatives

    • Table Abbott Laboratories SWOT analysis

    • Table GE Healthcare Life Sciences Profiles

    • Table GE Healthcare Life Sciences Production, Value, Price, Gross Margin 2014-2019

    • Table GE Healthcare Life Sciences Product benchmarking

    • Table GE Healthcare Life Sciences Strategic initiatives

    • Table GE Healthcare Life Sciences SWOT analysis

    • Table Pacific Biosciences Profiles

    • Table Pacific Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Pacific Biosciences Product benchmarking

    • Table Pacific Biosciences Strategic initiatives

    • Table Pacific Biosciences SWOT analysis

    • Table ZS Genetics Profiles

    • Table ZS Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table ZS Genetics Product benchmarking

    • Table ZS Genetics Strategic initiatives

    • Table ZS Genetics SWOT analysis

    • Table Hamilton Thorne Biosciences Profiles

    • Table Hamilton Thorne Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Hamilton Thorne Biosciences Product benchmarking

    • Table Hamilton Thorne Biosciences Strategic initiatives

    • Table Hamilton Thorne Biosciences SWOT analysis

    • Table Agilent Technologies Profiles

    • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Agilent Technologies Product benchmarking

    • Table Agilent Technologies Strategic initiatives

    • Table Agilent Technologies SWOT analysis

    • Table Bayer Corporation Profiles

    • Table Bayer Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Corporation Product benchmarking

    • Table Bayer Corporation Strategic initiatives

    • Table Bayer Corporation SWOT analysis

    • Table Microchip Biotechnologies Profiles

    • Table Microchip Biotechnologies Production, Value, Price, Gross Margin 2014-2019

    • Table Microchip Biotechnologies Product benchmarking

    • Table Microchip Biotechnologies Strategic initiatives

    • Table Microchip Biotechnologies SWOT analysis

    • Table LI-COR Biosciences Profiles

    • Table LI-COR Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table LI-COR Biosciences Product benchmarking

    • Table LI-COR Biosciences Strategic initiatives

    • Table LI-COR Biosciences SWOT analysis

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

    • Table Beckman Coulter Profiles

    • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

    • Table Beckman Coulter Product benchmarking

    • Table Beckman Coulter Strategic initiatives

    • Table Beckman Coulter SWOT analysis

    • Table Commonwealth Biotechnologies Profiles

    • Table Commonwealth Biotechnologies Production, Value, Price, Gross Margin 2014-2019

    • Table Commonwealth Biotechnologies Product benchmarking

    • Table Commonwealth Biotechnologies Strategic initiatives

    • Table Commonwealth Biotechnologies SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US